Product correctly added to cart.

discount label
LY 404039
View 3D

Biosynth logo

LY 404039

CAS: 635318-11-5

Ref. 3D-FL65070

10mg
184.00 €
50mg
483.00 €
Estimated delivery in United States, on Tuesday 21 May 2024

Product Information

Name:
LY 404039
Synonyms:
  • Pomaglumetad
  • (1R,4S,5S,6S)-4-Amino-2-Thiabicyclo[3.1.0]Hexane-4,6-Dicarboxylic Acid 2,2-Dioxide (Ly 404039)
  • (1R,4S,5S,6S)-4-Amino-2-thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid 2,2-dioxide
  • 2-Thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid, 4-amino-, 2,2-dioxide, (1R,4S,5S,6S)-
  • Ly 404039
  • Ly 404040
Description:

LY-404039 is a potent metabotropic glutamate receptor agonist with nanomolar affinity for group II receptors mGluR2 (Ki = 149 nM) and mGluR3 (Ki = 92 nM). It modulates glutamatergic activity in limbic and forebrain areas and has antipsychotic properties in animal studies. LY-404039 represents a potential new therapy for neurophysiatric disorders including schizophrenia, psychosis and anxiety.

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
235.01506
Formula:
C7H9NO6S
Purity:
Min. 95%
Color/Form:
Solid
InChI:
InChI=1S/C7H9NO6S/c8-7(6(11)12)1-15(13,14)4-2(3(4)7)5(9)10/h2-4H,1,8H2,(H,9,10)(H,11,12)/t2?,3?,4-,7-/m0/s1
InChI key:
InChIKey=AVDUGNCTZRCAHH-NJTBGMRFSA-N
SMILES:
N[C@@]1(C(=O)O)CS(=O)(=O)[C@H]2C(C(=O)O)C21
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-FL65070 LY 404039

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".